Collaborative Research TGen actively partners with leading institutions and companies such as Barrowneuro, Dell Technologies, and Deepcell, creating opportunities for collaborative projects and data management solutions tailored to advanced biotech research and clinical diagnostics.

Cutting-Edge Technologies The company's focus on integrating AI, cloud computing, and innovative imaging platforms indicates a strong need for advanced technology solutions, IT infrastructure, and data analytics tools to support their complex genomic and biomedical research activities.

Growth Potential Having received significant funding and being part of City of Hope, TGen is expanding its clinical network and research capabilities, making it a promising partner for companies offering research infrastructure, funding, and clinical trial services.

Disease Focus TGen’s recent projects targeting rare genetic diseases like limb-girdle muscular dystrophy and neurological disorders such as ALS and FTD suggest opportunities to supply specialized diagnostic tools, genetic testing services, and therapeutic development collaborations.

Market Positioning As a biotech research institute with a diverse industry network and ongoing innovations in genomics, TGen presents opportunities for vendors providing laboratory equipment, research consumables, and data analysis platforms aimed at accelerating translational medicine efforts.